Paediatric resuscitation
Paediatric resuscitation
- 9yo and above get ALS but have lower rates of shockable rhythm
- Neonatal guidelines for newborns and first hours after birth
- Infant <1yo
- Young child aged 1-8
- Older child aged 9-14
- Initial cardiac rhythm often asystole or severe bradycardia
- VF initial rhythm in 10%
- More likely if congenital cardiac disease, cardiotoxic agents, membrane channelopathies or during course of resuscitation
ALS
- Single rescuer and witnessed collapse – get help first then commence CPR
- If encounter unwitnessed collapse, start CPR first then get help
- Start chest compressions if unresponsive and not breathing normally, pulse not palpable within 10 seconds or is <60/min
- CPR should commence with 2 rescue breaths in infants and children
- 2:15 ratio (unlike BLS 2:30)
- Same rate (100-120/min)
- Compression depth 1/3 of chest (same) = 4cm in infants, 5cm in children
- Two thumb technique preferred for infants
- One or two-handed technique for children
- Two-handed technique for older children >8yo
- IO if no IV within 60 seconds
- 10 breaths/min once intubated (if LMA continue to deliver during pauses (vs. adults 12/min after either LMA or ETT)
- Investigate for membrane channelopathies after sudden unanticipated cardiac arrest
- Do not recommend compression only CPR unless rescuer cannot/will not provide rescue breaths
- Insert NG or OG tube early after intubation
Paediatric resuscitation
- etCO2
- No specific number for prognosis
- Low CO2 during CPR may indicate treatable cause (PTX, hypovolaemia, tamponade)
- High CO2 indicates hypoventilation
- Adrenaline and other vasoconstrictors can reduce etCO2 for 1-2 minutes post-delivery
- etCO2 of 10-15 despite 15-20min of ALS has strong association with inability to attain ROSC
- Drug dosing
- In non-obese victims, can approximate weight from length/height
- In obese victims, should use ideal body weight approximated from length/height (exception to this is suxamethonium)
- Subsequent doses should be based on clinical effect and toxicity
Paediatric resuscitation
- Weight for age
- Newborn = 3.5kg
- 1 year = 10kg
- 9 years and less = Age X 2 + 8
- 10 years and over = age x 3.3kg
- Can use height charts instead
- AED
- Can use if over 8 years old
- If under 8, preference is AED with paediatric attenuation but can use adult AED if only one available
- Unknown safety if under 1yo but case report of effective use
- Can still interpret rhythms effectively
Paediatric resuscitation – Drugs
- Drug delivery
- Flush with N/S (or dextrose for amiodarone)
- Adrenaline
- 10mcg/kg up to 1g after every 2nd loop (immediately in non-shockable and after 2nd failed shock in shockable)
- Larger doses in beta-blocker poisoning
- 100mcg/kg via ETT
- Can give infusion 0.1-0.2mcg/kg/min
- Amiodarone
- 5mg/kg IV/IO loading dose
- Limited evidence that may improve rates of survival to hospital admission vs. lignocaine
- Also useful for atrial tachycardia, resistant SVT, pulsatile VT, junctional ectopic tachycardia and wide-complex tachycardia
- Lignocaine
- 1mg/kg IV/IO/ET
- May increase rates of ROSC vs. amiodarone
- Can use either amiodarone or lignocaine for shock-resistant VF or pVT
Paediatric resuscitation – Drugs
- Atropine
- Indicated for vagal hyperstimulation and cholinergic drug toxicity
- Unclear if reduces incidence of bradycardia or cardiac arrest on intubation or if improves survival
- Many practitioners have it available for paediatric intubation but pre-loading is not recommended
- 20mcg/kg IV/IO or 30mcg/kg ETT
- Bradycardia caused by hypoxaemia should be treated with ventilation and oxygenation but if resistant, add adrenaline
- Severe bradycardia or bradycardia with hypotension should be treated with adrenaline
Paediatric resuscitation – Drugs
- Calcium
- Utilised in hyperkalaemia, hypocalcaemia, hypermagnesaemia or CCB toxicity
- Associated with worse outcome if used routinely
- 0.15mmol/kg for CCB toxicity (= 0,2mL/kg of 10% calcium chloride or 0.7mL/kg of 10% calcium gluconate)
- Glucose
- Normal 3-8mmol
- Hypoglycaemia seen commonly in infants with critical illness
- Hyperglycaemia associated with poorer outcomes
- Treat hypoglycaemia with 0.25g/kg glucose IV or IO (e.g. 0.5mL/kg of 50% glucose via CVL) or 2.5mL/kg of 10% dextrose
- Maintenance 5-8mg/kg/min
Paediatric resuscitation – Drugs
- Magnesium
- Preferred treatment for torsades de pointes due to acquired or congenital prolonged QT
- 0.1-0.2mmol/kg IV/IO followed by infusion of 0.3mmol/kg over 4 hours
- Potassium
- Hypokalaemia
- 0.03-0.07 mmol/kg slow injection over several minutes
- If critical but not imminently life-threatening, 0.2-0.5mmol/kg/hour infusion
- Need extreme caution and up to q30min repeat levels
- Hypokalaemia
Paediatric resuscitation – Drugs
- Procainamide
- Effective for haemodynamically stable SVT and VT in children
- 10-15mg/kg over 30-60min
- Sodium bicarbonate
- Limited and unproven place
- May exacerbate intracellular acidosis due to CO2 production
- Also risks hypernatraemia, hyperosmolality and depressed myocardial function
- May be useful in severe metabolic acidosis <7.1; prolonged arrest; hyperkalaemia and TCA overdose
- 0.5-1mmol/kg IV or IO after adequate ventilation and chest compressions initiated
Paediatric resuscitation – Drugs
- Vasopressin
- Unclear if beneficial
- 0.5-0.8U/kg IV or IO bolus if used
Arrhythmia management
- Asystole or severe bradycardia
- CPR if HR <60, abnormal breathing and unresponsive
- Adrenaline 10mcg/IV bolus if unresponsive to initial CPR repeated every 4 minutes
- Sodium bicarbonate 1mmol/kg IV/IO if prolonged arrest
- Pacing may be effective but should not interfere with CPR
Arrhythmia management
- VF or pVT
- If witnessed and monitored, defib first if within 20 seconds
- Praecordial thump can also be considered in this setting
- If within cardiac cath lab, ICU or cardiac ward post-surgery or other situations with defib already attached can do 3 stacked shocks
- 4J/kg for biphasic or monophasic shocks followed by 2 min of CPR without waiting to re-assess rhythm
- If fails, adrenaline 10mcg/kg IV or IO
- Persistent or refractory treat with amiodarone 5mg/kg as a bolus or lignocaine 1mg/kg
- Adrenaline every 2nd cycle
- If refractory consider sodium bicarbonate 1mmol/kg, magnesium 0.05-0.1mmol/kg and potassium chloride 0.05mmol/kg
- If witnessed and monitored, defib first if within 20 seconds
Arrhythmia management
- PEA
- Causes include intrinsic depressed myocardial contractility, hypoxaemia, hypovolaemia, hypo/hyperthermia, hyperkalaemia, hypocalcaemia, severe acidosis, tamponade, PE, tension PTX, toxins, CCB or air embolism
- Adrenaline 10mcg/kg
- If persistent, IV bolus of fluid and/or sodium bicarbonate 1mmol/kg
- CXR, 12-lead and echo are all useful in determining underlying remediable cause
Arrhythmia management
- SVT
- 220-300/min in infants; 180/min in children
- QRS narrow <0.08s in most cases (hard to differentiate from sinus tachy)
- HR in sinus tachycardia is variable vs. uniform sudden onset/offset in SVT
- In both rhythms, a P wave may be discernable
- If stable
- Vagal
- Infants and young children – iced-water bag on face or unilateral carotid massage
- Older children – Unilateral carotid massage or blowing through narrow straw
- Do not perform eyeball pressure
- Adenosine
- 0.1 to 0.2 to 0.3mg/kg sequentially (not to exceed 12mg)
- Amiodarone 5mg/kg over 1 hour then 5mcg/kg/min infusion
- Procainamide, digoxin, beta-blocker or CCB are alternatives
- Procainamide 15mg/kg over 30-60min (risk of hypotension through vasodilation)
- CCB should be avoided in infants and young children due to risk of hypotension and cardiac depression
- Vagal
- If unstable/arrest
- Synchronised DC cardioversion 0.5-1J/kg increased to 2J/kg if necessary
- Overdrive pacing may also be effective
Arrhythmia management
- Pulsatile VT
- Amiodarone 5mg/kg over 20-60min
- Procainamide 15mg/kg over 30-60 min
- Both prolong the QT and should not be used together
- Synchronised DC cardioversion 0.5-2J/kg if unstable
- Polymorphic VT
- MgSO4 0.1-0.2mmol/kg
- If pulseless, treat as for pulseless VT
- Wide QRS SVT
- Indistinguishable from VT in many cases
- If stable, treat as for SVT
- If unstable, regard as pulsatile VT and treat with synchronised DC cardioversion 0.5-2J/kg
- If pulseless, regard as pulseless VT and performed unsynchronised defibrillation 4J/kg
Techniques
- 100% O2 until ROSC then target SpO2 94-98% (same as adults) or PaO2 80-100
- If cyanotic heart disease, target PaO2 40-50 and SpO2 75-85%
- LMA sizing
- <5kg – Size 1
- 5-10kg – Size 1.5
- 10-20kg – Size 2
- 20-30kg – Size 2.5
- 30-50kg – Size 3
- 50-70kg – Size 4
- 70-100kg – Size 5
- >100kg – Size 6
Techniques
- ET size
- Uncuffed
- Newborn 2-3kg = Size 3mm
- Newborn >3kg = Size 3.5mm
- Infant up to 6mo = Size 3.5-4mm
- Infant 7mo to 1yo = Size 4mm
- Over 1yo = Age (years)/4 + 4
- Cuffed
- Newborns >3kg and <1yo = 3mm
- 1-2yo = 3.5mm
- >2yo = Age in years /4 + 3.5
- Uncuffed
Techniques
- Insertion length for oral tubes
- Newborn = 9cm from lips
- 6mo infant = 11.5cm
- 1 yo = 12cm
- >1yo = Age in years /2 + 12cm
- Insertion length for nasal tubes
- Newborn 11cm
- 6 months 13cm
- 1 year 14cm
- >1yo = Age in years/2 + 15cm
- Need to measure when head NOT extended i.e. after placement
Techniques
- IO
- Correct placement confirmed with aspiration of bone marrow or flushing without extravasation
- Can use bone marrow for biochem and haematological investigations but NOT VBG
- Can use any drug
- ET drugs
- Adrenaline, atropine and lignocaine all can be delivered this way
- Use water rather than saline as diluent
- Volume 0.7mL in newborns, 1-2mL for infant, 2-5mL for small child and 5-10mL for large child
Post-RESUS care
- Supportive therapy to continue
- Maintain adequate BP and oxygenation appropriate for age and long-term comorbidity
- Target at least 5th centile for age BP
- Target normocarbia
- Look for underlying cause
- Consider membrane channelopathy if sudden cardiac arrest
- Check for complications of CPR
- CXR, echo, bloods, gas
- Continued monitoring of haemodynamics, ECG, SpO2, etCO2, glucose, temp and end-organ function
- Maintain normoglycaemia with care to avoid hypoglycaemia
- Maintain normothermia (36-37.5) or hypothermia (32-34)
- Should institute TTM within 6 hours and continue for at least 24 hours and up to 72 hours in children who remain comatose after cardiac arrest
- Hyperthermia should be aggressively prevented and treated as associated with poorer outcomes
Prognosis
- Good prognostic indicators
- Any shockable rhythm at any stage
- IHCA age <1yo confers advantage
- OOHCA age >1yo confers advantage
- Drowning iced water or witnessed VF have better outcomes
- Should continue resuscitation efforts longer in these settings
- If respiratory arrest alone or in-hospital, better prognosis
- Duration of CPR is not a reliable indicator of outcomes
- Should use multiple indicators for prognostication
- EEG within 7 days, somatosensory evoked potentials (SSEP) after 72 hours, biomarkers of neuronal damage repeatedly over 72 hours, computerised axonal tomography in first hours and MRI during first 6 days
- May need to modify in setting of TTM, induced hypothermia, sedation
Cessation
- Combination of pre-arrest status, duration of arrest, response to resuscitation, reversible causes, duration and quality of CPR, likely outcome, opinions of experts, desires of parents and availability of ECMO
- In the absence of reversible causes, prolonged resuscitative efforts are rarely successful
- No legal obligation to persist indefinitely to try to save a life in this circumstance
- If deemed futile or not in child’s best interests, can cease treatment
Last Updated on October 13, 2020 by Andrew Crofton
Andrew Crofton
0
Tags :